Forphenicinol is an immunomodulator that enhances phagocytosis of yeast by peritoneal macrophages isolated from thioglycolate-stimulated mice; prevents cyclophosphamide-induced suppression of delayed-type hypersensitivity (DTH) and augments DTH responses to hapten oxazolone or sheep red blood cells in mice; enhances bactericidal activity of murine macrophages against Pseudomonas aeruginosa at a dose of 0.5 mg/kg; improves survival in a murine Pseudomonas aeruginosa infection model at doses of 15.6–1,000 μg per animal; and inhibits tumor growth in S180 sarcoma and IMC carcinoma murine xenograft models when administered daily at doses of 0.05–5 mg/kg.